Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical
Retrieved on:
Tuesday, February 23, 2021
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc.(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)(the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Linna Olofsson as an advisor and consultant for the Company.
Key Points:
- Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc.(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)(the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Linna Olofsson as an advisor and consultant for the Company.
- Her contribution to execute strategic marketing plans increased U.S. sales from $3.2 million in 2018 to $6.7 million in 2019.
- Dr. Linna Olofsson commented, "I'm beyond thrilled and honoured for this opportunity to join PreveCeutical as an advisor.
- PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.